GSK standardizes on Phase Forward's Inform EDC solution

Already a customer of Phase Forward's Clintrial clinical data management solution (CDMS), GSK will deploy InForm and Phase Forward consulting and support services across its Phase I-IV clinical tr

By Editor on Aug 24, 2004

Already a customer of Phase Forward's Clintrial clinical data management solution (CDMS), GSK will deploy InForm and Phase Forward consulting and support services across its Phase I-IV clinical trials. Phase Forward believes that, as GSK delivers its robust and expanding R&D pipeline, the use of the InForm solution will help the company to optimize the development process, enabling a reduction in overall program costs, enhanced decision making, and boost internal capacity.

"This electronic data management initiative promises to be an important tool in managing a larger number of trials while restraining costs," said Ted Chin, GSK eDM project leader and VP of Biometrics and Data Sciences, GSK.

Phase Forward said GSK will be able to expedite data capture and benefit from higher quality data, which will be visible and accessible earlier than using the traditional paper-based process. By streamlining development processes utilizing EDC, GSK expects to realize improved cycle times, more timely decisions on numbers of evaluable subjects per study, earlier decision-making from pivotal studies, and a reduction in the elapsed time to start on follow-on studies.

GSK selected Phase Forward to play this important role in its electronic data management (eDM) initiative based on a number of key factors: Phase Forward's ability to support GSK's long-term growth strategy, experience serving a large, global installed base, and leadership position in the industry. Through this expanded relationship, Phase Forward plans to work with GSK to provide a state-of-the-art architecture that Phase Forward believes will result in a highly scalable, interoperable environment for eDM.

"The competitive nature of the pharmaceutical marketplace drives companies to speed product time to market. Leading organizations such as GSK are taking measures to enhance the efficiency of the clinical trial process in order to increase trial capacity, reduce their R&D costs, and ultimately compress clinical development time," said Steve Powell, VP/GM International Operations, Phase Forward. "GSK recognizes that flexibility, functionality, and scalability are critical attributes for an electronic data management solution that supports global clinical trials, and we are pleased to provide its chosen solution. We look forward to assisting GSK establish a new global standard for streamlined clinical development processes."